Overall, our new findings highlight a potential antifibrotic role for SEMA3B and support modulating the SEMA3B-NRP1 axis as an innovative therapeutic approach to inhibit pulmonary fibrosis. Here, SEMA3B is linked to pulmonary fibrosis.